Yasushi Kisanuki, MD
Basic profileThe Ohio State University Wexner Medical Center
Yasushi Kisanuki is a Neurology physician affiliated with The Ohio State University Wexner Medical Center. OpenAlex indexes 13 publications with 510 citations (h-index 6).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
920 N Hamilton Rd Ste 500
Gahanna, OH 432301757
Telephone
614-293-4969Provider last certified this registry record 7 Aug 2025.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Mirum Pharmaceuticals, Inc.Program year202524 payments$55,108openpaymentsdata.cms.gov ↗
- Mirum Pharmaceuticals, Inc.Program year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Musculoskeletal
48.8%gamma-Aminobutyric Acid-ergic Agonist42.5%Baclofen100%Part D + Part B≥81 patientsCentral alpha-2 Adrenergic Agonist3.6%Tizanidine Hcl100%Part D≥13 patients+ 2 more classes in this area
Nervous system
42.2%Gabapentinoids15.8%Gabapentin64%Pregabalin36%Part D<11 patientsOther antiepileptics2.7%Levetiracetam100%Part D<11 patients+ 13 more classes in this area
Cardiovascular
4.1%Beta blocker4.1%Propranolol Hcl Er100%Part D≥13 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Benefits of eculizumab in AQP4+ neuromyelitis optica spectrum disorder: Subgroup analyses of the randomized controlled phase 3 PREVENT trial
Multiple Sclerosis and Related Disorders
2020 - Preface: promoting research in PLS: current knowledge and future challenges
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
2020 - How to join English teleconference on neurologicial diseases
Japanese Society of Neurology
2019
Similar KOLs
Other experts from the same institution or the same specialty.
Timothy Pawlik, MD
The Ohio State University Wexner Medical Center
Colleen Cebulla, MD
The Ohio State University Wexner Medical Center
Michael Grever, MD
The Ohio State University Wexner Medical Center
Brad Rovin, MD
The Ohio State University Wexner Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”